S. Herkenrath (Köln, Germany), E. Schwarz (Zürich, Switzerland), R. Bercea (Kolnes, Norway), M. Arzt (Regensburg, Germany)
The impact of obstructive sleep apnea in case of acute coronary syndrome
G. Calcaianu (Mulhouse, France), E. Virot (Mulhouse, France), D. Bresson (Mulhouse, France), M. Calcaianu (Mulhouse, France), C. Iamandi (Mulhouse, France), D. Debieuvre (Mulhouse, France)
|  |
Systematic coronary risk evaluation among obstructive sleep apnea patients
A. Kania (Krakow, Poland), G. Bochenek (Krakow, Poland), P. Nastalek (Krakow, Poland), N. Celejewska-Wojcik (Krakow, Poland), J. Pabjanczyk (Krakow, Poland), K. Regulski (Krakow, Poland), A. Opalinski (Krakow, Poland), B. Mrzyglod (Krakow, Poland), M. Glowacki (Krakow, Poland), K. Sladek (Krakow, Poland)
|  |
Obstructive sleep apnoea and cardiovascular events in a Chinese cohort
P. XU (Hong Kong, China), D. Fong (Hong Kong, China), C. Hui (Hong Kong, China), M. Lui (Hong Kong, China), D. Lam (Hong Kong, China), M. Ip (Hong Kong, China)
| |
Diagnosis of left ventricular diastolic dysfunction among obstructive sleep apnea patients
M. Yong (Kuching, Malaysia), D. Foo (Kuching, Malaysia), S. Kho (Kuching, Malaysia), S. Chan (Kuching, Malaysia), A. Fong (Kuching, Malaysia), S. Tie (Kuching, Malaysia)
| |
Correlations between severity of obstructive sleep apnoea and systolic pulmonary artery pressure: preliminary results
L. Marra (Bari, Italy), S. Cicco (Bari, Italy), G. Castellana (Bari, Italy), V. Di Lecce (Bari, Italy), P. Carratù (Bari, Italy), G. Ranieri (Bari, Italy), A. Vacca (Bari, Italy), O. Resta (Bari, Italy)
| |
Inverse relationship between objective snoring time and the prevalenc of plaque in women
J. Kim (Philadelphia, United States of America), A. Pack (Philadelphia, United States of America), B. Riegel (Philadelphia, United States of America), S. Lee (Ansan, Republic of Korea), C. Shin (Ansan, Republic of Korea)
| |
Thrombolysis and evolution of sleep apnea in ischemic stroke
J. Huhtakangas (Oulu, Finland), T. Saaresranta (Turku, Finland), J. Huhtakangas (Oulu, Finland)
| |
Sleep disorder level in stroke patients and related factors
s. parlak (yozgat, Turkey), H. YiLmaz (konya, Turkey), T. Bekci (konya, Turkey), L. Parlak (yozgat, Turkey)
| |
The importance of RDW in obstructive sleep apnea syndrome.
S. Beyhan Sagmen (Istanbul, Turkey), E. Torun Parmaksiz (Istanbul, Turkey), N. Kiral (Istanbul, Turkey), B. Salepci (Istanbul, Turkey), S. Comert (Istanbul, Turkey)
| |
Nocturnal respiratory failure in moderate sleep apnoea as predictive factor of cardiovascular and metabolic comorbidities
V. Di Lecce (Bari, Italy), L. Marra (Bari, Italy), G. Castellana (Bari, Italy), P. Carratù (Bari, Italy), V. Valerio (Bari, Italy), C. Santomasi (Bari, Italy), O. Resta (Bari, Italy)
| |
The efficiency of Epworth sleepness scale and Berlin questionnaire for detecting Obstructive sleep apnea syndrome(OSA) in 100 Tunisian patients with non valvular atrial fibrillation(AF)
A. Touil (Tunis, Tunisia), J. Ben Amar (Tunis, Tunisia), K. Sammoud (Tunis, Tunisia), M. Ben Halima (Tunis, Tunisia), S. Ouali (Tunis, Tunisia), M. Mourali (Tunis, Tunisia), B. Dhahri (Tunis, Tunisia), H. Zaibi (Tunis, Tunisia), H. Kchouk (Tunis, Tunisia), I. Laouini (Tunis, Tunisia), . Baccar (Tunis, Tunisia), S. Azzabi (Tunis, Tunisia), H. Aouina (Tunis, Tunisia)
| |
Effect of treatment of CSA/CSR on left ventricular ejection fraction in heart failure– a network meta-analysis
E. Schwarz (Zurich, Switzerland), F. Scherff (Zurich, Switzerland), S. Haile (Zurich, Switzerland), M. Kohler (Zurich, Switzerland)
| |
Recurrent heart rate rises, as a marker of sleep fragmentation, return more rapidly during CPAP withdrawal than oxygen desaturations
S. Pattenden (Oxford, United Kingdom), C. Turnbull (Oxford, United Kingdom), J. Stradling (Oxford, United Kingdom)
| |
Hypoxia effect on the hepatic profile, glucose metabolism and cardiovascular risk.
B. Aldave Orzaiz (Madrid, Spain), P. Landete Rodriguez (Madrid, Spain), C. Acosta Gutierrez (Madrid, Spain), M. Hernandez Olivo (Madrid, Spain), M. Gonzalez GonzáLez (Madrid, Spain), J. Muñoz Olmedo (Madrid, Spain), A. Friera Reyes (Madrid, Spain), A. Sanchez Azofra (Madrid, Spain), E. Zamora Garcia (Madrid, Spain), A. Gonzalez Rodriguez (Madrid, Spain), J. Soriano (Madrid, Spain), C. Garcia Monzon (Madrid, Spain), J. Ancochea Bermudez (Madrid, Spain)
| |
Ischemia modified albumin in Patients with Obstructive Sleep Apnea Syndrome
E. Seyhan (istanbul, Turkey), M. Düger (istanbul, Turkey), M. Bolatkale (istanbul, Turkey), Z. Kansu (istanbul, Turkey), E. Aynaci (istanbul, Turkey)
| |
Apelin and ischemia modified albumin levels in heart failure patients with sleep disordered breathing
B. Taskin Dogan (Gaziantep, Turkey), N. Bayram (Gaziantep, Turkey), M. Uyar (Gaziantep, Turkey)
| |
The effect of CPAP treatment on Galectin-3 level in patients with severe obstructive sleep apnea
I. Andreieva (Zaporizhyzhia, Ukraine)
| |
Effect of continuous positive airway pressure on lipid profile in patients with severe OSAS
B. Simon (Budapest, Hungary), B. Gabor (Budapest, Hungary), I. Barta (Budapest, Hungary), C. Paska (Budapest, Hungary), R. Szvatek (Budapest, Hungary), G. Boszormenyi Nagy (Budapest, Hungary), E. Vizi (Budapest, Hungary), B. Antus (Budapest, Hungary)
| |
The influence of long-term CPAP therapy on metabolic variables in obstructive sleep apnea patients
W. Kuczynski (Lodz, Poland), A. Stolarz (Lodz, Poland), P. Bialasiewicz (Lodz, Poland)
| |